Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    The Life of Marie Curie and Her Contributions to Oncology
    Cancer treatments
    The Life of Marie Curie and Her Contributions to Oncology
    November 07, 2022
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    Patient safety
    Post-Flooding Natural Disaster Cancer Considerations and Patient Education Points
    September 28, 2022
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    Radiation therapy
    Can Patients Use Continuous Glucose Monitors During Radiation Therapy for Cancer?
    August 19, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Symptom management

    Nurse-Led Online Intervention Improves Symptoms, Control, and QOL in Ovarian Cancer
    Ovarian cancer

    Nurse-Led Online Intervention Improves Symptoms, Control, and QOL in Ovarian Cancer

    An eight-week online symptom self-management program, which can be facilitated by a nurse, significantly improves symptom burden, sense of control, and quality of life among patients with ovarian cancer. Researchers reported the evidence in the Journal of Clinical Oncology.

    October 19, 2022
    New SIO-ASCO Guideline Identifies Integrative Care Recommendations for Cancer-Related Pain
    Pain management

    New SIO-ASCO Guideline Identifies Integrative Care Recommendations for Cancer-Related Pain

    Cancer-related pain, whether from the disease or its treatments, is a distressing symptom that persists through survivorship. Pain diminishes patients’ quality of life and negatively affects their cancer-related outcomes.

    October 14, 2022
    Precision Oncology Models Guide Tailored Nursing Interventions for Ovarian Cancer Symptom Clusters
    Ovarian cancer

    Precision Oncology Models Guide Tailored Nursing Interventions for Ovarian Cancer Symptom Clusters

    Using the National Institutes of Health Symptom Science Model and Nursing Science Precision Health Model helps oncology nurses to recognize symptoms more promptly in patients with ovarian cancer and provide precision interventions that address racial disparities and foster equity in symptom-focused, patient-centered care, Mahoney and Pierce reported in the October 2022 issue of the Clinical Journal of Oncology Nursing.

    October 11, 2022
    The Intersection of Pelvic Health and Oncology Optimizes Sexual Symptom Management
    Sexual/reproductive issues

    The Intersection of Pelvic Health and Oncology Optimizes Sexual Symptom Management

    Both a patient’s cancer and their subsequent treatment plan can affect their bodies, including pelvic health and sexual functioning. A pelvic health physical therapist can help combat—or even prevent—those issues as a member of the interprofessional cancer care team.

    October 04, 2022
    Nurses Use Innovation to Perform Symptom and Pain Assessments
    Symptom management

    Nurses Use Innovation to Perform Symptom and Pain Assessments

    Symptom and pain assessment tools can measure multiple aspects of a patient’s pain experience in both ambulatory and acute care settings. My interest in symptom assessment began with to my work as an oncology nurse practitioner, when I witnessed how symptom management can make a positive difference in patients’ lives and ability to tolerate cancer treatment.

    July 12, 2022
    The Clinical Pharmacist’s Role in Symptom Assessments
    Symptom management

    The Clinical Pharmacist’s Role in Symptom Assessments

    Healthcare professionals involved in direct patient care, such as nurses, pharmacists, advanced practice providers, and physicians, learn methods of symptom assessment during education and training, but each profession uses a slightly different lens. The ability to consider polypharmacy and drug-drug interactions in patient assessment is one of the most important skills a clinical pharmacist uses in daily practice. Clinical pharmacists caring for patients with cancer must identify drug-related side effects, monitor and manage patients during chronic drug therapy, and educate patients and members of the interprofessional team, all in the context of the intricacies of antineoplastic therapy and adherence assessment.

    July 05, 2022
    Symptom Assessment
    Symptom management

    Symptom Assessment

    Symptom assessment gives oncology nurses a consistent matrix to directly evaluate the significance that symptoms have on patients’ distress, quality of life, and survival. Both symptoms and their impact can evolve throughout a patient’s cancer course, making high-quality and detail-oriented assessments an essential tool for successful treatment and management.

    July 05, 2022
    Don’t Ask Patients About Their Symptoms—Have Them Tell You
    Symptom management

    Don’t Ask Patients About Their Symptoms—Have Them Tell You

    “How are you doing?” We ask this question of our patients repeatedly: at diagnosis, during treatment, throughout survivorship, and at end of life. However, studies show that patients often give inaccurate answers to that direct question.

    May 12, 2022
    ONS Launches New Learning Extension Activities for Popular Cancer Basics Course
    Press Releases

    ONS Launches New Learning Extension Activities for Popular Cancer Basics Course

    The Oncology Nursing Society’s (ONS’s) new Learning Extension Activities Plan (LEAP), an opportunity for student nurse learners to further develop their knowledge of some of the topics covered in ONS’s Cancer Basics course, was created to help faculty members teach oncology to nursing students.

    March 02, 2022
    Real-World Usage Reports Show That ONS Guidelines™ Empower Nurses to Provide Best Patient Care
    Putting evidence into practice (PEP)

    Real-World Usage Reports Show That ONS Guidelines™ Empower Nurses to Provide Best Patient Care

    Among their many benefits in practice, ONS Guidelines™ arm oncology nurses with the evidence to advocate for their patients’ care, according to findings from a fall 2021 focus group ONS conducted with nurses practicing at all levels of direct care.

    February 18, 2022
    Exercise the Evidence: How I Moved From an Idea to Program Development
    Patient quality of life

    Exercise the Evidence: How I Moved From an Idea to Program Development

    As a clinical nurse specialist (CNS) with a cardiovascular background, I have seen the evidence-based benefits of exercise in a variety of settings. However, several years ago, when I was working as a CNS on an acute inpatient oncology unit, I noticed that exercise was not regularly included in care plans. As I learned from staff, this was done out of concern that patients needed to rest to save their energy. 

    November 19, 2021
    Defining Individual Biosignatures Through Precision Health Symptom Science Helps Nurses Deliver Even Better Care
    Symptom management

    Defining Individual Biosignatures Through Precision Health Symptom Science Helps Nurses Deliver Even Better Care

    Understanding the underlying mechanisms of cancer­related symptoms enables oncology nurses to provide the best patient-centered care. Biosignatures are indicators of life, and in disease, they contribute to the determination of clinical profiles. Identifying specific biologic markers associated with similar patient characteristics and symptoms may help us create tailored interventions for improved symptom management.

    November 16, 2021
    Genetic Counselors Help Patients and Providers Understand Biomarker Testing Goals and Results
    Targeted therapy

    Genetic Counselors Help Patients and Providers Understand Biomarker Testing Goals and Results

    Genetic counselors have a unique ability to explain complex genetic information to patients, providers, and our healthcare colleagues and to empower patients to take an active role in their healthcare decisions. We review biosignature data points and help explain the difference between variants that were acquired (somatic) versus those that may have a germline component, or possibly inherited from a parent. By working with oncology teams, genetic counselors provide guidance on potential next steps to evaluate variation occurrences and how providers, patients, and their families can use the information to guide their care.

    November 02, 2021
    Bringing Biosignatures to the Bedside
    Targeted therapy

    Bringing Biosignatures to the Bedside

    With the growth of genomics and targeted therapy, nurse scientists are gaining deeper understanding the vast facets of patients’ symptom experience, and biosignatures could be the key to unlocking the next frontier in symptom science research.

    November 02, 2021
    ONS Bridge

    New Multiple Myeloma Treatments Present New Challenges in Side Effect Management

    New strategies are emerging to manage the complex side effects and adverse events from multiple myeloma (MM) therapies, Lorraine Mack, APN/MSN CNL, OCN®, AOCNS®, and Dodi Georges, MSN, CWON, OCN®, both from Northwestern Medicine, said during a session held September 14, 2021, at the ONS BridgeTM virtual conference. They shared best practices for nursing interventions for patients undergoing new treatment options.

    September 14, 2021
    Diagnose and Treat Hypercalcemia of Malignancy
    Advanced Practice Nursing (APRN)

    Diagnose and Treat Hypercalcemia of Malignancy

    Hypercalcemia of malignancy (HCM) is a common paraneoplastic syndrome associated with poor prognosis that affects approximately 20%–30% of patients with cancer. It’s most often seen in patients with breast, lung, renal, or ovarian cancers; squamous cell carcinoma of the head and neck; multiple myeloma; and certain lymphomas.

    July 15, 2021
    ONS Congress

    An APRN’s Clinical Guide to Medical Marijuana

    More and more patients with cancer are asking their healthcare providers whether medical marijuana can help them manage symptoms and side effects. Advanced practice RNs (APRNs) must be prepared to educate patients and assess their eligibility for therapeutic cannabis.

    April 29, 2021
    Nursing Management of Adverse Events From Enfortumab Vedotin Therapy for Urothelial Cancer
    Adverse events

    Nursing Management of Adverse Events From Enfortumab Vedotin Therapy for Urothelial Cancer

    Once patients stop responding to platinum-based chemotherapy for locally advanced or metastatic urothelial cancer, their treatment options had been somewhat limited: PD-1/PD-L1 inhibitors were effective in only 13%–29% of patients and taxanes in only 11%–13%. When the antibody drug conjugate enfortumab vedotin was approved in late 2019, it offered new hope for patients and providers, with clinical trials reporting a 44% objective response rate.

    April 13, 2021
    What the Evidence Says About Music Therapy for Cancer-Related Fatigue?
    Symptom management

    What the Evidence Says About Music Therapy for Cancer-Related Fatigue

    Cancer-related fatigue is a serious, debilitating symptom that affects nearly 90% of patients following treatment, with the majority reporting the adverse event at moderate to severe levels. It can prolong hospital stays and limit patients’ ability to complete their treatments and resume daily activities, ultimately affecting quality of life and survival. Despite high prevalence rates, cancer-related fatigue was reported as “inadequately addressed” in findings from a large multisite study.

    March 15, 2021
    Nurse Scientists Guide the Evidence in Symptom Science, and Inaugural Colloquium Recognizes That Impact on a National Level
    Oncology nurse scientist

    Nurse Scientists Guide the Evidence in Symptom Science, and Inaugural Colloquium Recognizes That Impact on a National Level

    Oncology nurses hold a unique position in improving symptom management and health outcomes in people with cancer, and their contributions to the body of symptom science are critical. In support of that work, ONS embarked on a landmark partnership with the National Institute of Nursing Research and National Cancer Institute's Center for Cancer Research to present the inaugural Colloquium on Symptom Science Advances in Oncology Nursing on February 4–5, 2021.

    March 05, 2021
    The Case of the Virtual Venture
    Clinical practice

    The Case of the Virtual Venture

    Staff in an oncology infusion unit located in an urban healthcare system watched as patient and caregiver stress increased during the COVID-19 coronavirus pandemic and the November 2020 U.S. presidential elections. During a team meeting, Holly, one of the nurses, brought up a study she read about that used virtual reality (VR) as a distraction for patients undergoing chemotherapy. The staff was interested in implementing a similar program at their institution but wasn’t sure how to start. What would you do?

    December 17, 2020
    Manage Cancer Treatment-Related Constipation With ONS Guidelines™
    Clinical practice guidelines

    Manage Cancer Treatment-Related Constipation With ONS Guidelines™

    As many as 43%–58% of patients with cancer experience constipation related to their treatment, and the side effect is both distressing and potentially life threatening if severe enough. Constipation-related emergency department visits increased by 41.5% from 2006–2011, with older adults (aged 85 years or older) making up most of the visits. Estimates suggest that the cost of managing severe cancer-related constipation may range from $500 to more than $2,300 per person per month. Supporting patients who experience the side effect is critical for their well-being.

    December 08, 2020
    Patients With Gynecologic Cancers Have Significant Fatigue After Surgery
    Cancer surgery

    Patients With Gynecologic Cancers Have Significant Fatigue After Surgery

    Forty-eight percent of women with gynecologic cancers report experiencing clinically significant fatigue after surgery that may continue six months (44%) and one (39%) year later, researchers reported in study findings published in Cancer.

    November 12, 2020
    ONS Center for Innovation Launches New Tool to Help Improve Patient Outcomes
    Press Releases

    ONS Center for Innovation Launches New Tool to Help Improve Patient Outcomes

    Cancer treatment often causes symptoms that result in treatment delays and unplanned care, which adversely affects patient outcomes, healthcare costs, and patient satisfaction. To decrease those possibilities, the ONS Center for Innovation launched ONS On-Call™, an oncology-specific decision support tool to guide standardized, evidence-based symptom assessment and leverage ONS’s proprietary evidence-based resources for patient-reported symptoms. Designed by nurses, the cloud-hosted tool ensures best practices in the clinic and institution by providing nurses with guided, comprehensive, and evidence-based assessments that illuminate the causative factors of patients’ symptoms and experience.

    October 26, 2020
    ONS Bridge

    Opioids Can Be Used Safely for Cancer-Related Pain

    During the current opioid epidemic, a safe, balanced approach to pain management is imperative. In an ONS Bridge presentation, Jeannine M. Brant, PhD, APRN, AOCN®, FAAN, discussed the use of opioids in patients with cancer.

    September 15, 2020
    ONS Guidelines™ Offer Framework for Managing Treatment-Related Hot Flashes
    Treatment side effects

    ONS Guidelines™ Offer Framework for Managing Treatment-Related Hot Flashes

    Because of treatment effects on hormones, women with breast cancer and men with prostate cancer have an increased risk of frequent and severe hot flashes after treatment. As many as 80% of patients across both genders experience the symptom, which can have an impact on sleep, mood, energy, and sexual function.

    September 10, 2020
    ONS Bridge

    Oncology Symptom Science Research Needs to Focus on New Therapies

    Immunotherapy, emerging therapies, precision health, and biosignatures are the next frontier for oncology symptom science research, specifically patient-reported outcomes and immune-related adverse events, researchers reported during a presentation on September 8, 2020, at the inaugural ONS Bridge™ virtual conference.

    September 08, 2020
    The Case of the Pancreatic Phenomenon
    Clinical practice

    The Case of the Pancreatic Phenomenon

    Ronnie, a 68-year-old patient with stage IV pancreatic ductal adenocarcinoma, recently started palliative FOLFIRINOX chemotherapy, a regimen consisting of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin, every two weeks. During his toxicity evaluation, prior to starting his second cycle, he describes a few concerning symptoms that have been ongoing for several weeks, including unintentional weight loss of 15 kg over the last two months, significant bloating after meals, and frequent flatulence with oily stools that are difficult to flush.

    August 28, 2020
    What the Evidence Says for Use of Quigong in Patients With Cancer
    Symptom management

    What the Evidence Says About Qigong in Patients With Cancer

    Qigong is a mind-body practice that originated in China nearly five millennia ago. It integrates movement, meditation, and breath regulation to improve physical and emotional health. The actions are slow, gentle, flowing, repetitious, and weight-bearing and can be adapted or practiced while sitting, standing, or walking. Qigong styles and forms vary widely, depending on the school of thought and philosophy.

    July 20, 2020
    Managing Cancer-Related PTSD Starts With Acknowledgement
    Patient empowerment

    Managing Cancer-Related PTSD Starts With Acknowledgement

    Post-traumatic stress disorder (PTSD) is often associated with survivors of military combat or natural disaster, such as refugees or veterans. However, patients with a current or past cancer diagnosis, and their loved ones, are at risk for developing cancer-related PTSD (CR-PTSD).

    July 14, 2020
    Myeloproliferative Neoplasm Symptoms, Diagnosis, Treatment, and Survivorship Recommendations
    Survivorship

    Myeloproliferative Neoplasm Symptoms, Diagnosis, Treatment, and Survivorship Recommendations

    Myeloproliferative neoplasms are a group of blood cancers that start with a small mutation in the stem cells of the bone marrow. Although MPNs are quite rare, essential thrombocythemia, polycythemia vera, and myelofibrosis are the most common types. Each represents a mutation of a different source of stem cell.

    July 09, 2020
    Manage Thrombosis in Patients With Cancer
    Symptom management

    Manage Thrombosis in Patients With Cancer

    Thrombotic events are the second-leading cause of death in patients with cancer after the disease itself. An estimated 4%–20% of patients experience venous thromboembolism at some stage on the cancer journey. 

    April 09, 2020
    Cardio-Oncology Program Monitors Heart Toxicities Throughout Survivorship
    Symptom management

    Cardio-Oncology Program Monitors Heart Toxicities Throughout Survivorship

    Cancer is second only to heart disease as the leading cause of death in the United States. But heart conditions overlap with cancer in more ways than mortality. Chemotherapy, immunotherapy, radiation, and the myriad medication combinations used in cancer can lead to various complications, including cardiotoxic side effects. Because of the prevalence of heart disease, many patients with cancer also present with pre-existing cardiac comorbidities.

    February 11, 2020
    Does Cryotherapy Prevent Extremity Toxicities From Taxane Chemotherapy?
    Treatment side effects

    Does Cryotherapy Prevent Extremity Toxicities From Taxane Chemotherapy?

    As many as 50% of patients receiving taxane chemotherapy have reported experiencing peripheral neuropathy (PN) or nail changes during treatment. Both are potentially dose-limiting adverse events: nail changes can lead to infections; PN affects patients’ ability to perform activities of daily living and results in sensory impairments such as loss of balance, muscle weakness, and numbness that can increase patients’ risk for falls.

    January 07, 2020
    Experts Recommend Tailored Exercise for All Cancer Treatment Plans
    Research

    Experts Recommend Tailored Exercise for All Cancer Treatment Plans

    Systemic use of exercise prescriptions not only lowers the risk of certain cancers but also helps to improve side effects and survival from cancer and should therefore be incorporated into cancer treatment plans, experts from the American College of Sports Medicine and 17 partner organizations said in articles published in Medicine and Science in Sports and Exercise and CA: A Cancer Journal for Clinicians.

    December 25, 2019
    Draft ONS Guideline Open for Public Comment
    Clinical practice guidelines

    Draft ONS Guideline Open for Public Comment

    As part of the rigorous process of transitioning ONS Putting Evidence Into Practice recommendations into formal, actionable clinical practice guidelines, the draft guidelines must undergo a public comment period. The first five guidelines to reach that step will be open for public comment in December 2019 and early 2020.

    December 02, 2019
    How Can Oncology Nurses Collaborate With Dietitians to Manage Malnutrition?
    Treatment side effects

    How Can Oncology Nurses Collaborate With Dietitians to Manage Malnutrition?

    Nutrition impact symptoms (NIS) involve any barrier to a patient’s nutritional status. Cancer and its treatments often lead to complex side effects that develop rapidly and change in character and intensity throughout treatment. Barriers to eating and drinking, digesting, and absorbing nutrients lead to negative clinical outcomes for patients with cancer, including malnutrition. Prompt assessment and interventions are key to helping patients avoid treatment holidays and dose reductions while also promoting the best possible quality of life during their cancer journey. In fact, a weight loss of just 5% is an indicator that a patient will likely not receive all of his or her prescribed cancer treatment.

    November 05, 2019
    Manage Cancer-Associated Anemia With Erythropoietin-Stimulating Agents
    Advanced Practice Nursing (APRN)

    Manage Cancer-Associated Anemia With Erythropoietin-Stimulating Agents

    As a side effect of cancer or its treatment, anemia is associated with reduced quality of life, thanks to symptoms such as palpitations, fatigue, dyspnea, and dizziness. Etiology is often multifactorial with contributing factors such as suppression of hematopoiesis from malignancy or cancer treatments, bleeding, nutritional deficiencies, renal insufficiency, or hemolysis.

    October 31, 2019
    Pneumonitis With Immunotherapy Treatment
    Immunotherapy

    Pneumonitis With Immunotherapy Treatment

    Pneumonitis is inflammation of the lung parenchyma; although rare, it can be fatal. Nishino et al. found that the overall incidence of pneumonitis with PD-1 inhibitor monotherapy was 2.7% for all-grade and 0.8% for grade 3 or higher pneumonitis. Naidoo et al. reported an approximate 5% incidence of all-grade pneumonitis, although the incidence of all-grade pneumonitis is higher with combination immunotherapy (up to 10%). The incidence is more common with higher grades in PD-1 inhibitors (versus PD-L1 inhibitors), but it occurs less often with anti-CTLA4 monoclonal antibodies. 

    September 23, 2019
    To Prevent Hepatoxicity, Monitor Liver Function During Cancer Treatment
    Advanced Practice Nursing (APRN)

    To Prevent Hepatoxicity, Monitor Liver Function During Cancer Treatment

    Because the liver is the primary site of metabolism for many drugs, baseline function testing and monitoring during cancer treatment are essential. However, the cause of an abnormal liver function test when a patient is receiving chemotherapy or immunotherapy can be difficult to determine. 

    August 28, 2019
    Evidence Shows Tai Chi May Be Useful for Insomnia
    Complementary therapy

    Evidence Shows Tai Chi May Be Useful for Insomnia

    Nearly 60% of people with cancer experience insomnia; it can persist for years if not appropriately managed. Furthermore, patients with cancer who have insomnia are at increased risk for infections, anxiety, and depression, which can negatively affect quality of life.

    August 22, 2019
    Diagnose and Manage Dermatologic Toxicity Secondary to Immunotherapy
    Advanced Practice Nursing (APRN)

    Diagnose and Manage Dermatologic Toxicity Secondary to Immunotherapy

    Dermatologic toxicity is the most common side effect secondary to immunotherapy. The majority of dermatologic adverse events are mild to moderate rashes on the truck of the body and upper extremities, pruritis, and vitiligo. The most common is maculopapular rash with erythematous macules, papules, and/or plaques that can sometimes be scaly; pruritis is also frequent but often underreported and undertreated and may affect quality of life.

    July 25, 2019
    FDA Approves Ruxolitinib for Acute Graft-Versus-Host Disease
    U.S. Food and Drug Administration (FDA)

    FDA Approves Ruxolitinib for Acute Graft-Versus-Host Disease

    On May 24, 2019, the U.S. Food and Drug Administration (FDA) approved ruxolitinib (Jakafi®) for steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older.

    May 24, 2019
    Acupuncture for Cancer-Related Fatigue
    Complementary therapy

    Acupuncture for Cancer-Related Fatigue

    Fatigue is one of the most prevalent and challenging side effects that people with cancer experience. Commonly known as cancer-related fatigue (CRF), the National Comprehensive Cancer Network  defines it as “a distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity and interferes with usual functioning.” CRF affects 50%–90% of patients and can diminish quality of life, lead to functional impairment, and is associated with significant morbidity. Although it improves in many patients the year following treatment, CRF may persist over a much longer period in some.

    May 14, 2019
    The Case of the Terrible Toxicities
    Adverse events

    The Case of the Terrible Toxicities

    After completing neoadjuvant chemotherapy for triple-negative invasive breast cancer, Madeline, age 32, had a bilateral mastectomy with reconstructive surgery. Final pathology showed residual disease in the breast and one lymph node, and her oncologist recommended adjuvant therapy with capecitabine (1,500 mg twice a day for 14 days, off for 7 days). Five weeks postoperatively, she started cycle 1. Eight days later, her husband called the cancer clinic reporting that over the past two days, his wife developed profound weakness, unremitting diarrhea despite using diphenoxylate and atropine as directed, and painful, red, swollen hands and feet. Her symptoms represented a drastic change from her usual routine and energy level.

    May 14, 2019
    Tachycardia Tied to Higher Mortality in Patients With Cancer
    Symptom management

    Tachycardia Tied to Higher Mortality in Patients With Cancer

    Rates of all-cause mortality in patients with cancer increase in the presence of unexplained sinus tachycardia, the results of a new study show. Researchers presented the findings at the Advancing Cardiovascular Care of the Oncology Patient conference held January 2019 in Washington, DC.

    April 24, 2019
    ONS Congress

    Early Intervention Can Help Preserve Function in Spinal Cord Compression

    Spinal cord compression (SCC)—an oncologic emergency—is the initial presentation in roughly 20%–33% of patients with a malignancy, Carol S. Viele RN, MS, OCN®, of the University of California, San Francisco, School of Nursing, said during a session on Saturday, April 13, 2019, at the ONS 44th Annual Congress in Anaheim, CA. Nurses can play a key role in recognizing the condition and getting patients into early treatment that may help preserve their function, she said.

    April 13, 2019
    ONS Congress

    Nurses Must Help Patients Use Cannabis Safely

    Regardless of their own feelings or biases about cannabis, nurses must recognize that their patients are using it and help them to access the drug safely, Eloise Theisen, MSN, RN, AGPCNP-BC, of the Radicle Health Clinician Network in Walnut Creek, CA, said during a session on Saturday, April 13, 2019, at the ONS 44th Annual Congress in Anaheim, CA. Many patients with cancer are using cannabis and are looking to their healthcare providers for information on how they can use it to reduce their symptoms, she said.

    April 13, 2019
    ONS Congress

    Here’s How ONS Is Transitioning Symptom Management Resources Into Guidelines

    Using the best evidence to inform care leads to better patient outcomes and can prevent over- or underuse of healthcare resources. Clinical practice guidelines are an important tool for healthcare providers to ensure they are using informed care in their practice. On Friday, April 12, 2019, at the ONS 44th Annual Congress in Anaheim, CA, Pamela Ginex, EdD, RN, discussed ONS’s symptom management guidelines and a new initiative to develop and implement guidelines into clinical care.

    April 12, 2019
    ONS Congress

    Nurses Need to Recognize the Unique Needs of Older Adults With Cancer

    The number of U.S. adults aged 65 and over is rapidly increasing: by 2030, they’re estimated to represent about 70% of cancer diagnoses. During a session on Friday, April 12, 2019, at the ONS 44th Annual Congress in Anaheim, CA, speakers discussed how the complexities of cancer care can affect the expanding population of older adults with cancer.

    April 12, 2019
    • Current page 1
    • Page 2
    • Page 3
    • Next page
    • Last page Last »
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    View All Topics
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲